Washington Lawmakers Advance Marijuana Homegrow Bill While Nixing Proposal To Ban High-THC Product Sales To People Under 25
Ohio Officials Release First Proposed Marijuana Licensing Rules Amid Push For Expedited Adult-Use Sales Blood Glucose Meter Readings
U.S. Senator And Congressman Urge Feds To Fully Legalize Marijuana, Rather Than Reschedule It
DEA Rehires Agent Fired Over Positive Drug Test From CBD, Agreeing To Provide Back Pay In Lawsuit Settlement
Majority Of U.S. Military Service Members, Veterans And Their Families Support Marijuana Legalization, Poll Finds
American Medical Association Says Safe Drug Consumption Sites ‘Save Lives’ By Reducing Risky Behaviors And Overdose Deaths
Dogs Given CBD See ‘Significant Reductions’ In Stress And Anxiety Related To Riding In Cars, Study Finds
CDC Finds Youth Marijuana Use Fell In Washington State’s Largest County After Adult-Use Legalization
Marijuana Study Comparing U.S. And Canada Finds Broad Legalization Support And Similar Use Rates Despite Differing National Policies
Scientists Discover The Exact Reason Marijuana Causes The ‘Munchies’ In New Federally Funded Study
Treasury Secretary Yellen Says She Over-Prepared For First Time Using Marijuana And Jokes That It ‘Always Helps’ With Candy Crush
NFL Partnering On New Study Using CBD To Treat Pain And Protect From Concussions
NCAA Division I To Vote On Removing Marijuana From Banned Substances List For Student Athletes
UFC Formally Removes Marijuana From Banned Substances List For Professional Fighters
State Officials Promote Marijuana Gifting, Infused Baking And Safety Tips For The Holiday Season
Multiple States Across The Country See Record-Breaking Marijuana Sales To Close Out 2023
Massachusetts Sets Marijuana Sales Record In December, With Total Purchases In 2023 Reaching $1.8 Billion
Missouri Sold More Than $1.3 Billion Worth Of Legal Marijuana In 2023, State Figures Show
Michigan Marijuana Sales Surpassed $3 Billion In 2023 As Retailers Smashed Monthly Record In December
Rhode Island Marijuana Retailers Shatter Monthly Sales Record, Capping Off $100 Million In Cannabis Purchases In 2023
U.S. Senator And Congressman Urge Feds To Fully Legalize Marijuana, Rather Than Reschedule It
Biden Falsely Suggests Marijuana Pardons ‘Expunged’ Records And Released Prisoners While Campaigning On ‘Promises Kept’
Fetterman Opposes Schumer’s Zyn Nicotine Pouch Crackdown For Same ‘Freedom’ Reasons He Backs Marijuana Legalization
Ohio Marijuana Law Has Created A ‘Goofy Situation,’ Governor Says, With Legal Possession But No Place To Buy It
DeSantis On Federal Gun Ban For Marijuana Users: ‘I Don’t Think That’s Constitutional, To Be Honest With You’
NY gov “fed up” with cannabis market launch (Newsletter: January 29, 2024)
DOJ cannabis pardon certificates (Newsletter: January 26, 2024)
Uber & other companies lobby on cannabis (Newsletter: January 25, 2024)
DOJ asks court not to “disrupt” cannabis scheduling review (Newsletter: January 24, 2024)
DOJ wants to dismiss cannabis lawsuit (Newsletter: January 23, 2024)
The Drug Enforcement Administration (DEA) has rehired and will provide back pay to a special agent who was fired after testing positive for THC that he attributed to CBD he was taking as an opioid alternative for chronic pain, with the agency reaching a settlement agreement in a lawsuit challenging the termination.
After being fired in 2019 over the random drug screening, Anthony Armour filed suit against DEA in the U.S. Court of Appeals for the Federal Circuit last year, asserting that the agency didn’t have grounds to remove him after using what he believed to be a federally legal hemp product, without evidence he intended to break the law.
Last week, Armour prevailed—with DEA agreeing to reinstate him, with some back pay and restored eligibility for a pension.
The New York Times first reported that the agency also agreed to cover the plaintiff’s legal expenses, though one court filing in the case said that “each side shall bear its own attorney fees, costs and expenses.”
Throughout the lawsuit, the Justice Department acknowledged that Armour was an “outstanding” special agent during his 16-year tenure, but they said his “reckless” conduct in consuming CBD justified the termination.
“I’m excited to be getting back to work at DEA,” Armour, who was expected to return to the agency’s Houston office on Monday, told The Times. “I hope to finish my career at DEA by helping its mission in taking dangerous drugs like fentanyl off the streets.”
As argued by Armour’s attorney Matt Zorn, DEA notably did not have a CBD policy for its workforce at the time of the termination, which came about a year after hemp and its derivatives were federally legalized under the 2018 Farm Bill.
The agency did amend its policy for job applicants in 2021, updating a questionnaire to only ask about hemp and cannabidiol use prior to the crop’s federal legalization. Multiple federal departments have similarly adopted CBD guidance that generally caution against using the non-intoxicating cannabinoid in the years since.
The settlement agreement with DEA also comes as the agency completes a broader review into marijuana scheduling under a 2022 directive from President Joe Biden. The top federal health agency has recommended moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), but DEA has maintained that it has “final authority” in the matter.
There was a question raised in Armour’s case whether a Schedule III reclassification would prevent DEA from enforcing the employment penalty, as the agency had relied on a Reagan-era executive order to define an “illegal drug,” which is any Schedule I or Schedule II controlled substance that is not prescribed.
For his part, Armour told Marijuana Moment last year that he does personally “support legalization,” calling it a “common sense” policy.
“Obviously, the science backing legalization is there, and it’s just been ignored this entire time,” he said. “Thankfully, we have people that are able to bring the issue to light and educate a lot of people.”
Meanwhile, DEA has also called for the production of even more THC, psilocybin and DMT for research purposes than it initially proposed for 2024—raising its quotas for those drugs while maintaining already high production goals for marijuana and other psychedelics.
DEA has touted its Schedule I drug production quotas as evidence that is supports rigorous research into the substances, but it’s faced criticism from advocates and scientists over actions that are viewed as antithetical to promoting studies.
For example, DEA announced last month that it is taking another shot at banning two psychedelics after abandoning its original scheduling proposal in 2022, teeing up another fight with researchers and advocates who say the compounds hold therapeutic potential.
The agency separately backed down from a proposal to ban five different tryptamine psychedelics in 2022 amid sizable pushback from the research and advocacy communities.
Read legal documents in Armour’s lawsuit against the DEA below:
Biden Falsely Suggests Marijuana Pardons ‘Expunged’ Records And Released Prisoners While Campaigning On ‘Promises Kept’
U.S. Senator And Congressman Urge Feds To Fully Legalize Marijuana, Rather Than Reschedule It
Majority Of U.S. Military Service Members, Veterans And Their Families Support Marijuana Legalization, Poll Finds
Kyle Jaeger is Marijuana Moment's Sacramento-based managing editor. His work has also appeared in High Times, VICE and attn.
Washington Lawmakers Advance Marijuana Homegrow Bill While Nixing Proposal To Ban High-THC Product Sales To People Under 25
Treasury Secretary Yellen Says She Over-Prepared For First Time Using Marijuana And Jokes That It ‘Always Helps’ With Candy Crush
Ohio Officials Release First Proposed Marijuana Licensing Rules Amid Push For Expedited Adult-Use Sales
U.S. Senator And Congressman Urge Feds To Fully Legalize Marijuana, Rather Than Reschedule It
Majority Of U.S. Military Service Members, Veterans And Their Families Support Marijuana Legalization, Poll Finds
Biden Falsely Suggests Marijuana Pardons ‘Expunged’ Records And Released Prisoners While Campaigning On ‘Promises Kept’
Rapid Flu Swab All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell